Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research UK

This page shows the latest Cancer Research UK news and features for those working in and with pharma, biotech and healthcare.

Cancer Research UK study finds different responses to COVID-19 among cancer patients

Cancer Research UK study finds different responses to COVID-19 among cancer patients

A study funded by Cancer Research UK (CRUK) has found differing immune responses to COVID-19 among cancer patients, with certain cancer patients experiencing similar response to those without cancer, while ... Of the participants with cancer, 23 had

Latest news

More from news
Approximately 17 fully matching, plus 130 partially matching documents found.

Latest Intelligence

  • Can digital communications boost behaviour change? Can digital communications boost behaviour change?

    Using a ‘one-size-fits-all’ approach can result in poor uptake or even backlash, such as Cancer Research UK being accused of fat-shaming while trying to raise awareness of ... And with 80% of people in the UK now owning smartphones, individualised

  • Building Europe’s next breakthrough biotechs Building Europe’s next breakthrough biotechs

    Its founding investors include Cambridge Innovation Capital, Babraham Research Campus through Babraham Bioscience Technologies, Roche's biotech arm Genentech, and Dr Jonathan Milner and Dr Ian Tomlinson, two of the ... life sciences campus in central

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    genetic research through to drug development in pharma, and into leadership of several successful UK biotech firms. ... She is also a Women of Influence Mentor for Cancer Research UK and a public governor for The Christie NHS Foundation Trust in

  • Combined immunotherapies – potential and pitfalls Combined immunotherapies – potential and pitfalls

    A recent review of the current landscape of clinical research in cancer immunotherapy counted more than 3, 000 trials enrolling patients, including more than 1, 000 trials evaluating combinations with ... This view is shared by Professor Charles Swanton,

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    Scientists from the UK’s Medical Research Council Laboratory of Molecular Biology – which pioneered the sequencing of DNA – are already working with AstraZeneca counterparts and they will have places in the ... The park is also home to the Cancer

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Glythera has appointed new chief scientific officer Dr Robert Lutz to lead the advancement of the UK-based biotech's antibody drug conjugate portfolio. ... Additionally, Dr Jon Roffey joins Glythera’s scientific advisory board (SAB) from Cancer

  • Storm Therapeutics strengthens its board Storm Therapeutics strengthens its board

    Workman currently serves The Institute of Cancer Researc h as its president and chief executive officer and has formerly served as head of the division of cancer therapeutics at Cancer Research ... world class cancer institute and being a founder of

  • Cancer Research UK's Karen Vousden to join BMS board Cancer Research UK's Karen Vousden to join BMS board

    Cancer Research UK's Karen Vousden is set to join Bristol-Myers Squibb’s board of directors in January. ... Vousden is currently chief scientist at Cancer Research UK, as well as serving as group leader at the Francis Crick Institute in London, will

  • Sophie Adlard joins J+D Consulting as a business analyst Sophie Adlard joins J+D Consulting as a business analyst

    She brings experience from Cancer Research UK, where she was a PhD student. ... market research and forecasting projects going forward.”.

  • Hollingsworth leaves cancer charity for ABPI Hollingsworth leaves cancer charity for ABPI

    Andrew Hollingsworth appointed policy manager at pharma industry body. Andrew Hollingsworth is to leave the third sector to join industry, moving from Cancer Research UK to the Association of the British ... He leaves his role as public affairs manager

More from appointments
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 12 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics